← 전체 보충제 목록

규조토

Diatomaceous Earth

📑 PubMed 10편 📦 기타

📚 관련 논문 (10편)

1.
Postprandial metabolism of a reduced-fat meat product with added silicon from diatomaceous earth. A pilot randomized controlled four-way assay in humans.
Food & function 2025 PMID:40999964

44. Food Funct. 2025 Oct 13;16(20):8038-8047. doi: 10.1039/d5fo00973a. Postprandial metabolism of a reduced-fat meat product with added silicon from diatomaceous earth. A pilot randomized controlled four-way assay in humans. Vaquero MP(1), Álvarez MD(1), Zapatera B(1), Saiz A(1), Cofrades S(1).

2.
Diatoms embedded, self-assembled carriers for dual delivery of chemotherapeutics in cancer cell lines.
International journal of pharmaceutics 2020 PMID:31765771

21. Int J Pharm. 2020 Jan 5;573:118887. doi: 10.1016/j.ijpharm.2019.118887. Epub 2019 Nov 22. Diatoms embedded, self-assembled carriers for dual delivery of chemotherapeutics in cancer cell lines. Kabir A(1), Nazeer N(2), Bissessur R(1), Ahmed M(3). Author information: (1)Department of Chemistr

3.
The effects of MDCO-2010, a serine protease inhibitor, on activated clotting time in blood obtained from volunteers and cardiac surgical patients.
Anesthesia and analgesia 2012 PMID:22584552

41. Anesth Analg. 2012 Aug;115(2):244-52. doi: 10.1213/ANE.0b013e3182576a5a. Epub 2012 May 14. The effects of MDCO-2010, a serine protease inhibitor, on activated clotting time in blood obtained from volunteers and cardiac surgical patients. Kim H(1), Szlam F, Tanaka KA, van de Locht A, Ogawa S,

4.
The effects of aprotinin on thromboelastography with three different activators.
Anesthesiology 2001 PMID:11684986

32. Anesthesiology. 2001 Nov;95(5):1169-74. doi: 10.1097/00000542-200111000-00021. The effects of aprotinin on thromboelastography with three different activators. Avidan MS(1), Da Fonseca J, Parmar K, Alcock E, Ponte J, Hunt BJ. Author information: (1)Department of Anestesiology, Guy's, King's a

5.
In vitro and in vivo studies to assess the effectiveness of cholestyramine as a binding agent for fumonisins.
Mycopathologia 2001 PMID:11678589

41. Mycopathologia. 2001;151(3):147-53. doi: 10.1023/a:1017999013702. In vitro and in vivo studies to assess the effectiveness of cholestyramine as a binding agent for fumonisins. Solfrizzo M(1), Visconti A, Avantaggiato G, Torres A, Chulze S. Author information: (1)Istituto Tossine e Micotossin

6.
Re: "Dose-response associations of silica with nonmalignant respiratory disease and lung cancer mortality in the diatomaceous earth industry".
American journal of epidemiology 1998 PMID:9690370

2. Am J Epidemiol. 1998 Aug 1;148(3):307-9. doi: 10.1093/oxfordjournals.aje.a009641. Re: "Dose-response associations of silica with nonmalignant respiratory disease and lung cancer mortality in the diatomaceous earth industry". Mirliss MJ. Comment on Am J Epidemiol. 1997 Apr 15;145(8):680-8

7.
Re: "Dose-response associations of silica with nonmalignant respiratory disease and lung cancer mortality in the diatomaceous earth industry".
American journal of epidemiology 1998 PMID:9690369

6. Am J Epidemiol. 1998 Aug 1;148(3):307; author reply 308-9. doi: 10.1093/oxfordjournals.aje.a009640. Re: "Dose-response associations of silica with nonmalignant respiratory disease and lung cancer mortality in the diatomaceous earth industry". Gibbs GW. Comment on Am J Epidemiol. 1997 Apr

8.
Dose-response associations of silica with nonmalignant respiratory disease and lung cancer mortality in the diatomaceous earth industry.
American journal of epidemiology 1997 PMID:9125994

38. Am J Epidemiol. 1997 Apr 15;145(8):680-8. doi: 10.1093/aje/145.8.680. Dose-response associations of silica with nonmalignant respiratory disease and lung cancer mortality in the diatomaceous earth industry. Checkoway H(1), Heyer NJ, Seixas NS, Welp EA, Demers PA, Hughes JM, Weill H. Author i

9.
Aprotinin prolongs activated and nonactivated whole blood clotting time and potentiates the effect of heparin in vitro.
Anesthesia and analgesia 1996 PMID:8638779

32. Anesth Analg. 1996 Jun;82(6):1126-31. doi: 10.1097/00000539-199606000-00005. Aprotinin prolongs activated and nonactivated whole blood clotting time and potentiates the effect of heparin in vitro. Despotis GJ(1), Filos KS, Levine V, Alsoufiev A, Spitznagel E. Author information: (1)Departmen

10.
The prolonged activated clotting time (ACT) with aprotinin depends on the type of activator used for measurement.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1993 PMID:7681331

12. Blood Coagul Fibrinolysis. 1993 Feb;4(1):41-5. The prolonged activated clotting time (ACT) with aprotinin depends on the type of activator used for measurement. Wendel HP(1), Heller W, Gallimore MJ, Bantel H, Müller-Beissenhirtz H, Hoffmeister HE. Author information: (1)Department of Thorac

⚠️ 면책 고지

이 정보는 일반 교육 목적이며 의료 진단/처방을 대체하지 않습니다.